Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mannose-binding lectin genotype and phenotype in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

Diabetes care - 1 Nov 2010

Mellbin L G, Hamsten A, Malmberg K, Steffensen R, Rydén L, Ohrvik J, Hansen T K

Abstract excerpt

OBJECTIVE: The present study characterizes mannose-binding lectin (MBL), an activator of the complement system and thereby important for inflammatory activation, in patients with diabetes and myocardial infarction. RESEARCH DESIGN AND METHODS: Serum (S)-MBL was determined at hospital admission in 387 patients with type 2 diabetes (median age 70 years; 68% male) with myocardial infarction, and genotyping was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Kaplan-Meier Estimate

Share to Mannose-Binding Lectin

Share to Myocardial Infarction

Share to Phenotype

Share to Proportional Hazards Models

Source

Open in PubMed Open full text

Identifiers

PMID: 20693349
DOI: 10.2337/dc10-0903
PMCID: PMC2963511

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mannose-binding lectin genotype and phenotype in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.PMID 20693349Read ↗

Mannose-Binding Lectin and Risk of Cardiovascular Events and Mortality in Type 2 Diabetes: A Danish Cohort Study.Semantic proximity Read ↗

Increased all-cause mortality in patients with type 1 diabetes and high-expression mannan-binding lectin genotypes: a 12-year follow-up study.Semantic proximity Read ↗

Association between mannose-binding lectin and vascular complications in type 1 diabetes.Semantic proximity Read ↗

Low Mannose-Binding Lectin (MBL) genotype is associated with future cardiovascular events in type 2 diabetic South Asians. A prospective cohort study.Semantic proximity Read ↗

Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: the Strong Heart Study.Semantic proximity Read ↗

High MBL-expressing genotypes are associated with deterioration in renal function in type 2 diabetes.Semantic proximity Read ↗

Mannose-binding lectin and risk of infections in type 2 diabetes: A Danish cohort study.Semantic proximity Read ↗

Mannose-binding lectin deficiency is associated with myocardial infarction: the HUNT2 study in Norway.Semantic proximity Read ↗

Distinct Longitudinal Associations of MBL, MASP-1, MASP-2, MASP-3, and MAp44 With Endothelial Dysfunction and Intima-Media Thickness: The Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) Study.Semantic proximity Read ↗

Genetic and other factors determining mannose-binding lectin levels in American Indians: the Strong Heart Study.Semantic proximity Read ↗

Mannose-binding lectin as a risk factor for acute coronary syndromes.Semantic proximity Read ↗

Evaluation of lectin pathway activity and mannan-binding lectin levels in the course of pregnancy complicated by diabetes type 1, based on the genetic background.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.